Retrobulbar chlorpromazine in the treatment of painful absolute glaucoma. Five years experience

Authors

  • José Guillermo Martínez Urbay Hospital Provincial Universitario “Arnaldo Milián Castro”, Santa Clara, Villa Clara
  • Berta Gregoria Depestre Pérez Hospital Provincial Universitario “Arnaldo Milián Castro”, Santa Clara, Villa Clara
  • Abdel Bermúdez del Sol Hospital Provincial Universitario “Arnaldo Milián Castro”, Santa Clara, Villa Clara
  • Ruben Antoliano Rangel Fleites

Keywords:

glaucoma, therapeutics, chlorpromazine

Abstract

Treatment of severe and prolonged pain in blind eyes is one of the problems facing the Ophthalmology Specialist today. In order to assess the effect of the retrobulbar injection of chlorpromazine in the treatment of painful absolute glaucoma a prospective longitudinal case series study was performed in patients with this disease treated at the Department of glaucoma of Ophthalmologic Center in Arnaldo Milian Castro" Surgical Hospital " from the City of Santa Clara, Villa Clara province , from September 1, 2007. Patients underwent to a retrobulbar injection and its effect was evaluated weekly; at one, three, six and twelve months and then annually to complete the five- year follow-up. The variables pain, eye strain and treatment complications were evaluated. There was a study with 43 eyes of an equal number of patients  who experienced a reduction in pain from 9.3 to 2.7 on the visual scale of severity and decreased eye strain from 34.8mmHg 54.3mmHg up to five years of follow-up for 35.9% of  reduction. Complications were few and lenient. We conclude that positive results had retrobulbar injection to relieve pain and reduce eye strain in absolute painful glaucoma patients without causing severe side effects.

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
Martínez Urbay JG, Depestre Pérez BG, Bermúdez del Sol A, Rangel Fleites RA. Retrobulbar chlorpromazine in the treatment of painful absolute glaucoma. Five years experience. Acta Méd Centro [Internet]. 2014 Jun. 28 [cited 2025 Jun. 29];8(2):23-30. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/116

Issue

Vol. 8 No. 2 (2014): April-June

Section

Original Articles

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).